Microsoft commits that humans will remain accountable for AI systems and that meaningful oversight will be maintained, especially for important decisions.
This accountability commitment is most significant for consumers in contexts where Microsoft AI influences high-stakes decisions such as medical diagnosis, credit decisions, or employment screening, but the document does not specify what 'meaningful human oversight' requires in practice or how consumers can verify it is being applied.
How other platforms handle this
Other than the rights and responsibilities described in this section (Settling disputes, governing law, and courts), Google doesn't make any specific promises about the services. For example, we don't make any commitments about the content within the services, the specific functions of the services,...
This Usage Policy is calibrated to strike an optimal balance between enabling beneficial uses and mitigating potential harms. Anthropic may enter into contracts with certain governmental customers that tailor use restrictions to that customer's public mission and legal authorities if, in Anthropic's...
To rely upon the Services, the Materials, or the Actions to buy or sell securities or to provide or receive advice about securities, commodities, derivatives, or other financial products or services, as Anthropic is not a broker-dealer or a registered investment adviser under the securities laws of ...
Human oversight is a critical safeguard against AI errors causing serious harm, particularly in healthcare, criminal justice, and financial decisions where automated errors can have life-altering consequences.
(1) REGULATORY FRAMEWORK: EU AI Act Art. 14 mandates human oversight measures for all high-risk AI systems, specifying that natural persons must be able to monitor, intervene, and override AI outputs. GDPR Art. 22(2)(b) permits automated decision-making only with suitable safeguards including human review. NIST AI RMF Map and Manage functions address human oversight requirements. Sector-specific requirements include FDA guidance on AI/ML-based Software as a Medical Device (SaMD) and OCC guidance on model risk management (SR 11-7) for financial services AI. (2)
Compliance intelligence locked
Regulatory citations, enforcement risk, and due diligence action items.
Watcher: regulatory citations. Professional: full compliance memo.